These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 26508185)
21. [Current state of diagnosis and treatment of incomplete Kawasaki disease]. Zhang QY; Du JB Zhonghua Er Ke Za Zhi; 2006 May; 44(5):339-41. PubMed ID: 16780709 [No Abstract] [Full Text] [Related]
22. [Elective phagocytosis of polynuclear neutrophils caused by medullary macrophages and autoimmune neutropenia in children]. Gbadoe AD; Fenneteau O; Duval M; Rohrlich P; Cartron J; Vilmer E Arch Pediatr; 1997 May; 4(5):398-405. PubMed ID: 9230986 [TBL] [Abstract][Full Text] [Related]
23. Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange. Fujimaru T; Ito S; Masuda H; Oana S; Kamei K; Ishiguro A; Kato H; Abe J Cytokine; 2014 Dec; 70(2):156-60. PubMed ID: 25082649 [TBL] [Abstract][Full Text] [Related]
32. [Intravenous immunoglobulin-resistant Kawasaki disease with hemophagocytosis]. Servel AC; Vincenti M; Darras JP; Lalande M; Rodière M; Filleron A Arch Pediatr; 2012 Jul; 19(7):741-4. PubMed ID: 22652521 [TBL] [Abstract][Full Text] [Related]
33. The Harada score in the US population of children with Kawasaki disease. Tewelde H; Yoon J; Van Ittersum W; Worley S; Preminger T; Goldfarb J Hosp Pediatr; 2014 Jul; 4(4):233-8. PubMed ID: 24986993 [TBL] [Abstract][Full Text] [Related]
34. Serum levels of neutrophil activation cytokines in Kawasaki disease. Suzuki H; Noda E; Miyawaki M; Takeuchi T; Uemura S; Koike M Pediatr Int; 2001 Apr; 43(2):115-9. PubMed ID: 11285059 [TBL] [Abstract][Full Text] [Related]
35. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin. Khowsathit P; Hong-Hgam C; Khositseth A; Wanitkun S J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785 [TBL] [Abstract][Full Text] [Related]